(Q33494104)
Statements
1 reference
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC). (English)
1 reference
Chauvergne J
1 reference
Fumoleau P
1 reference
Cappelaere P
1 reference
Metz R
1 reference
Armand JP
1 reference
Chevallier B
1 reference
Kerbrat P
1 reference
de Forni M
1 reference
Lhommé C
1 reference
Roche H
1 reference
1 January 1993
1 reference
1 reference
29A
1 reference
350-354
1 reference
Identifiers
1 reference
1 reference